265 related articles for article (PubMed ID: 19782679)
1. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
Choi KH; Rhim H
Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
[TBL] [Abstract][Full Text] [Related]
2. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
3. Modulation of native T-type calcium channels by omega-3 fatty acids.
Danthi SJ; Enyeart JA; Enyeart JJ
Biochem Biophys Res Commun; 2005 Feb; 327(2):485-93. PubMed ID: 15629140
[TBL] [Abstract][Full Text] [Related]
4. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
5. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
Freeze BS; McNulty MM; Hanck DA
Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
[TBL] [Abstract][Full Text] [Related]
6. Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels.
Shcheglovitov A; Zhelay T; Vitko Y; Osipenko V; Perez-Reyes E; Kostyuk P; Shuba Y
Biochem Pharmacol; 2005 Mar; 69(5):841-54. PubMed ID: 15710361
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of T-type Ca(2+) channels in embryonic chick nodose ganglion neurons.
Pachuau J; Martin-Caraballo M
Dev Neurobiol; 2007 Dec; 67(14):1901-14. PubMed ID: 17874458
[TBL] [Abstract][Full Text] [Related]
8. Zn(2+) slows down Ca(V)3.3 gating kinetics: implications for thalamocortical activity.
Cataldi M; Lariccia V; Marzaioli V; Cavaccini A; Curia G; Viggiano D; Canzoniero LM; di Renzo G; Avoli M; Annunziato L
J Neurophysiol; 2007 Oct; 98(4):2274-84. PubMed ID: 17699699
[TBL] [Abstract][Full Text] [Related]
9. Temperature dependence of T-type calcium channel gating.
Iftinca M; McKay BE; Snutch TP; McRory JE; Turner RW; Zamponi GW
Neuroscience; 2006 Nov; 142(4):1031-42. PubMed ID: 16935432
[TBL] [Abstract][Full Text] [Related]
10. Effects of raloxifene on voltage-dependent T-type Ca2+ channels in mouse spermatogenic cells.
Wang Q; Lu L; Gao X; Wang C; Wang J; Cheng J; Gao R; Xiao H
Pharmacology; 2011; 87(1-2):70-80. PubMed ID: 21228613
[TBL] [Abstract][Full Text] [Related]
11. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
[TBL] [Abstract][Full Text] [Related]
12. Imatinib-mesylate blocks recombinant T-type calcium channels expressed in human embryonic kidney-293 cells by a protein tyrosine kinase-independent mechanism.
Cataldi M; Gaudino A; Lariccia V; Russo M; Amoroso S; di Renzo G; Annunziato L
J Pharmacol Exp Ther; 2004 Apr; 309(1):208-15. PubMed ID: 14718589
[TBL] [Abstract][Full Text] [Related]
13. Mammalian voltage-gated calcium channels are potently blocked by the pyrethroid insecticide allethrin.
Hildebrand ME; McRory JE; Snutch TP; Stea A
J Pharmacol Exp Ther; 2004 Mar; 308(3):805-13. PubMed ID: 14634047
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
[TBL] [Abstract][Full Text] [Related]
15. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
16. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
17. Voltage- and use-dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent.
Trezise DJ; John VH; Xie XM
Br J Pharmacol; 1998 Jul; 124(5):953-63. PubMed ID: 9692781
[TBL] [Abstract][Full Text] [Related]
18. Voltage-dependent calcium channels.
Lacinová L
Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
[TBL] [Abstract][Full Text] [Related]
19. T-type Ca2+ channels encode prior neuronal activity as modulated recovery rates.
Uebachs M; Schaub C; Perez-Reyes E; Beck H
J Physiol; 2006 Mar; 571(Pt 3):519-36. PubMed ID: 16423851
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and Gbetagamma modulation of Ca(v)2.2 channels with different auxiliary beta subunits.
Meir A; Dolphin AC
Pflugers Arch; 2002 May; 444(1-2):263-75. PubMed ID: 11976940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]